No top menu
<!-- no script -->
|
|
UT pharmacy faculty member, pharmacy graduate recognized for top-cited article |
| By
Jim Winkler |
|
Jul 2, 2008
|
|
A scientific article authored by a College of Pharmacy faculty member and 2007 PharmD graduate has been named the second most-cited article published in the journal Pharmacotherapy in 2007.
Authors of the article on echinocandins are Dr. Diane Cappelletty, associate professor of pharmacy practice and co-director of the Infectious Disease Research Laboratory, and PharmD graduate Kasi Eiselstein-McKitrick, who is working full-time for a local Toledo drug store and part-time at an onology clinic.
The article was published in March 2007 and detailed a new family of anti-fungal medicines called echinocandins.
“Echinocandins are the newest class of anti-fungal agents,” Cappelletty explained. “There are three drugs within this class, and the paper is a review article about these three drugs. The article provides an in-depth review of the pharmacokinetics and clinical outcomes with each of these agents in both adult and pediatric patients.”
A highly ranked citation usually demonstrates other scientists consider the article important and the subject matter worth continuing investigation.
The journal is the official publication of the American College of Clinical Pharmacy and has its editorial offices at Tufts University Medical Center in Boston. It is published 12 times per year and has a circulation of around 10,000 with subscribers in the United States, Canada, Mexico, Europe, the Middle East and Asia.
Cappelletty, who joined UT in 2001, received her bachelor of science in pharmacy and doctor of pharmacy degrees from Ohio State University and completed a postdoctoral fellowship in infectious diseases at Wayne State University in Detroit.
She co-directs the department’s infectious disease and critical-care fellowship program and teaches immunology, pathophysiology, infectious diseases and pharmacotherapy courses.
Cappelletty maintains a practice with the UT Medical Center infectious diseases service. Her research interests focus on infections in patient populations, pharmacokinetics and pharmacodynamics of antimicrobials, and resistance to antimicrobials.
Cappelletty is president-elect of the Society of Infectious Diseases Pharmacists (SIDP) and will be the organization’s president in October, succeeding Dr. Richard Drew, a Duke University Medical Center infectious diseases clinical pharmacist.
She previously was secretary/treasurer and president-elect of the society.
The Austin, Texas-based society that has more than 400 members was founded in 1990 and works with other health-care organizations such as the American Society for Microbiology, American College of Clinical Pharmacy, Infectious Diseases Society of America and the Society of Healthcare and Epidemiology of America to encourage appropriate use of antimicrobials and limit the spread of antimicrobial resistance.
A member of several national clinical pharmacy organizations, Cappelletty is a past chair of the SIDP Research Awards Committee and has earned research awards from the SIDP and the American Association of Colleges of Pharmacy.
|
|
| |
|
|
|
|
|
|
|
|
|
|
